2018
DOI: 10.1016/j.jpba.2017.11.070
|View full text |Cite
|
Sign up to set email alerts
|

SPR imaging biosensor for the quantitation of fibronectin concentration in blood samples

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 34 publications
0
32
0
Order By: Relevance
“…SPR sensors have also been used in diverse healthcare biosensing applications, bioimaging paediatric burns [75] as well as in the study of mutations [76] and the effects of radiation exposure [77]. Recent studies have also shown the versatility of such devices in the study of pathogens [78], thermal injuries [79], carcinogens [80] and several clinically vital molecules [81][82][83].…”
Section: Surface Plasmon Resonance Sensors For Biomedical Diagnosticsmentioning
confidence: 99%
“…SPR sensors have also been used in diverse healthcare biosensing applications, bioimaging paediatric burns [75] as well as in the study of mutations [76] and the effects of radiation exposure [77]. Recent studies have also shown the versatility of such devices in the study of pathogens [78], thermal injuries [79], carcinogens [80] and several clinically vital molecules [81][82][83].…”
Section: Surface Plasmon Resonance Sensors For Biomedical Diagnosticsmentioning
confidence: 99%
“…In addition, the sensitivity is affected by the auto-fluorescence of the analytes and the incubation time of the assay, while the specificity is contaminated by the non-specific interaction between the label. On the contrary, the high sensitivity and specificity with a high percentage of correlations between results obtained in the conventional assay ELISA and the developed SPRi of the label-free SPRi method is supported by an established protocol, and it is therefore the solution for molecular sensing work [126].…”
Section: Biosensing Applicationsmentioning
confidence: 99%
“…In Figure 10, the deposition of fibronectin (FN), a glycoprotein that is an essential component of the extracellular matrix (ECM), is imaged and quantified. FN present in the plasma acts as a potential biomarker indicating cell adhesion, growth, migration, differentiation, wound healing and embryonic development, and the quantification of the fibronectin concentration shows a dynamic response range between 5 and 400 ng/mL, with a detection limit of 1.5 ng/mL that supports a reliable screening of patients (601 ± 72 g/mL) from healthy donors (140 ± 25 g/mL) [126].…”
Section: Biosensing Applicationsmentioning
confidence: 99%
“…The papers pertaining to stages (iii) and (iv) represent complete analytical procedures [14,15,16,17,18,19,20,21,22,23,24,25,26,27]. These biosensors and related analytical procedures are ready to be subjected to clinical investigation for subsequent use in diagnosis.…”
Section: Stages Of Biosensor Developmentmentioning
confidence: 99%
“…Example of non-fluidic measurement. Reproduced with permission from [27]. Copyright 2017 Elsevier B.V.…”
Section: Figurementioning
confidence: 99%